Life-Science New Build Report: 200 North American Sites in Planning Represent Potential $15 Billion Investment
Life-Science New Build Report: 200 North American Sites in Planning Represent Potential $15 Billion Investment
Attachment: North American Life Science Industry, Nov. 2014
SUGAR LAND--November 4, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--It has become difficult, if not nearly impossible, for many of America's politicians to find common ground at any level. The outlier in this case appears to be the courting and landing of new life science industry facilities. In North America alone, there are currently 200 reported new-facility builds on the books, representing a total investment value of $15.4 billion.
Within this article: Details on the Pharmaceutical-Biotech Industry, including projects from such heavyweights as Baxter International Incorporated (NYSE:BAX), Gilead Sciences and Cosmax US Corporation.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Takeda Completes $62 Billion Shire Acquisition, an Industrial Info Market B...
- California Gears Up for $3.9 Billion in Third-Quarter Project Completions
- It's a Wrap! Pharma-Biotech Industry Set To Complete 268 North American CAP...
- Top 10 U.S. States Land $37.7 Billion in Active Pharmaceutical-Biotech Indu...
- Pharma-Bio Industry Capital Construction Monitor: Projects Underway in Nort...